Dallas- there has been no run up on Trimesta. Many are waiting to see, but could very well be scrambling to chase this higher on Partnership announcement. We know it's coming soon. I'm not going to be watching from the sidelines trying to buy as shares get vacuumed up upon a positive Partnership announcement.
It is actually very bullish. Maxim will help run and has a stake in the share price going up as the Market Maker. They most likely will he out for big returns particularly given the ridiculously low Market Cap here and opportunity here. We have seen this in other stocks and in a matter of 60 days, the stock price triples or quadruples. The large institutional haunts (54+%) and minute market cap relative to the science here makes this a steal at this level IMO. Good luck whatever you decide to do.
P.S. Watch having any stops in place on this one. Look at Friday where we took a quic dip and was back trading at the high of the day at market close. Know what you own here!!!
Looks like you were born on yahoo a few days ago, and it shows. The company is cashed up and ready to roll. Maxim has interest in running the stock up as they have done in other situations before they even think about cashing in on the warrants at .32 and .40. They are not flipping for pennies given the MC and huge potential in the Alzheimer's space.
It's a golden opportunity that won't last long at current levels. I see that the ONCS board has been made aware if this opportunity, but most have not. It is under the radar and way Undervalued. I've got $ clearing Monday to round my full position out.
Dallas,..maybe you should sell all of your shares here on Monday,..core and all if you truly believe what you are saying. As MDR stated in so many words,..this is not just a "Trimesta play." With that said, I believe that investors here will be rewarded once Riley announces who the Partner is. Q2 will be fun!
I should have clarified,...the phase 2 results next quarter are for Alzheimer's, which is their main emphasis as a company. Look at Pran's run up into Phase 2 last year. It gives some indication where AVXL might be headed.
Thought I would throw one out there - AVXL targeting Alzheimer's and other neurological disorders. Epilepsy findings due out on 5/15 at a conference. Phase 2 Results out next quarter. What makes this so intriguing is the minuscule market cap. It is dirt cheap. Institutional ownership is 54% as well. Check out AVXL Ihub for due diligence information. There is a sticky note there that is quite good. Also good posts on yahoo message board from Ctixer, Sal and others.
Bump- not a one trick pony. The value proposition here just gets better. This was great news this week. More for investors to chew on while they stare at the tiny MC on this one!
AVXL is still dirt cheap. I mean dirt cheap, but won't last long. Conference on 5/15 where they will be announcing Epilepsy findings. Read some of Sal's & Ctixer's posts on yahoo message board.
The chart is a thing of beauty and close at the high of the day. If we break .48 next week, could be looking at mid 60s. Conference on 5/15,...MC dirt cheap. Need more funds to clear,...
Sal, those that are thinking of selling here have a golden opportunity to make it back and MUCH more with AVXL. Finished at the high of the day,..time to get in is now IMO! Conference on May 15th! I think it's $2 by the time Data comes out in September.
If you have interest, then go to ihub and read JBem's sticky note and recent postings. Read Sal's and Ctixer posts on ymb. Too much to point out here. Good luck!
A Trimesta deal is not priced in IMO. That is why we are not at $4-$5 right now. Most of the big players talk about SYN-004 when SYN comes up. A deal is coming within 60 or so trading days if not any day now. Relax!
Hard pressed to find a better risk/reward in biotech. MC ridiculously low,...then you have another shot on goal with epilepsy to boot,..I am buying all I can while it is still under .50
Sentiment: Strong Buy